INTRODUCTION
A series of integrated studies was initiated a few years ago in an attempt to assess the sensitivity of 2 hybrid strains of mice to carcinogenic stimuli at specific age periods. Animals of both sexes were exposed to either a single or a limited number of administrations of the N-nitroso compounds ENU 3 (19) , N-nitroso-N,N-diethylamine (10) , or of the polycyclic aromatic hydrocarbon, BP. While ENU under physiological conditions undergoes spontaneous, rapid, heterolytic decomposition generating a short-acting carcinogenic moiety in all tissues (2, 5) , N-nitroso-N,N-di- 1These investigations have been supported in part by Contract NIH-NCI-69-2087 from the National Cancer Institute.
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Received April 21, 1975 ; accepted June 20, 1975. ethylamine and BP (4, 6, 8, 14) require the presence of specific enzymes for their activation to a carcinogenic moiety. The latter capability varies from tissue to tissue, thus restricting the carcinogenicity of the agent to the tissue(s) possessing enzymatic activity and susceptibility at the time procarcinogen is administered. This report deals with the roles of age, sex, and strain on carcinogenesis in several tissues following single administration of BP.
MATERIALS AND METHODS
Mice. The 1st generation of C57BL/6J x C3HeB/FeJ and C3HeB/FeJ • A/J hybrids, hereafter called B6C3F1 and C3AFa, respectively, were used. The parent strains had been purchased from The Jackson Laboratory, Bar Harbor, Maine. Animals were housed in plastic cages in groups of 10 and were kept in temperature-controlled laboratories. Sanicel was used as bedding, and Rockland mouse diet and water were given ad libitum. At 2-week intervals, the animals were weighed and inspected for the presence of any external neoplasms or other signs indicating the development of internal tumors and/or nonspecific pathological changes.
Treatment. BP, after being checked for purity, was dissolved (0.75 and 1.50%) in trioctanoin (Eastman Kodak Co., Rochester, N. Y.) at the time of treatment and was administered as specified in Table 1 . Four nontreated and 1 solvent-treated group served as the source of information on the spontaneous tumor development in each of the hybrids (19) .
Duration of Experiment. Groups of nontreated control mice were killed at 52, 90, and 142 weeks of age, whereas survivors of a 4th set of nontreated controls and a set of trioctanoin-treated groups were killed at 170 weeks. Animals given BP were observed throughout their life-spans. Complete autopsies were performed on all of the animals, and specimens from grossly visible tumors and other tissues were taken for histological evaluation. The specimens were fixed in buffered formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin.
Statistical Analysis of Data. The incidence of tumors of a given organ was calculated from the number of animals still alive in each experimental group at the time that a tumor of that organ was first observed at autopsy. The X 2 method of analysis was applied in the assessment of difference in tumor incidence between groups, while the differences in the average age at which tumors were detected at autopsy were 2948 CANCER RESEARCH VOL. 35
Research. 
RESULTS
The animals tolerated BP administration well, since practically none died due to its toxic effect within 4 weeks following treatment with the carcinogen. The effects of the carcinogen were manifested late in life in the variation of the survival rates of the animals, their body weights, and the incidence and spectrum of tumors that developed.
In general, animals treated at 42 days of age had lower weight loss and lived 10 to 20 weeks longer than mice given BP at birth or in infancy. The females of both strains lived 10 to 20 weeks longer than the males of comparable groups. Of the 2 hybrid strains, the B6C3F1 strain showed better survival. The mortality of the animals, in general, was associated with development of tumors, mainly of the liver, the stomach, and the lymphoreticular system. Development of Tumors in the Controls. Detailed information on the incidence of tumors in the nontrcated controls has been presented in a paper reporting on the multicarcinogenicity of ENU which was evaluated concurrently with this study and used the same biological system (19) . For proper evaluation of the presented data and at the same time to avoid repetition in toto, Table 2 presents only the incidences of tumors observed in animals sacrificed at 90 and 142 weeks. By the 90th wcck of life, tumors had developed at a low incidence with the exception of lung adenomas observed in the C3AFa males (49%) and females (26%) (p < 0.01). At 142 weeks of age, however, various primary tumors were observed in both strains, each type of neoplasm not exceeding an incidencc of 10%, except lung tumors, which developed in 60% of male and 40% of female C3AF~ mice, in contrast with only 13 and 9% observed in the B6C3F~ male and female mice, respectively.
Development of Tumors in BP-treated Animals. The primary tumors developed in 9 organs (Table 3) but principally in the liver, lung, stomach, and lymphoreticular system. Liver Tumors. Table 4 presents the incidence of liver tumors and the average age of mice at the time of tumor detection at autopsy. In general, hepatomas developed with significantly higher incidence (p < 0.01) and at an earlier age in mice that were treated with BP within 24 hr of birth or at 15 days of age than they did in animals receiving similar treatment at 42 days of age. In the latter case, the incidence of hepatomas was essentially the same as that observed in the nontreated controls ( Table 2) .
Females of both strains developed hepatomas with significantly lower incidence than did corresponding male mice (p < 0.01 ). This incidence did not differ significantly from that observed in the nontreated controls with the exception of B6C3F1 females treated at birth. Given i.p. in 0.01 ml of trioctanoin per g of body weight. M  90  97  49  3  3  0  0  0  0  0  142  100  60  8  4  3  2  3  0  2   F  90  100  26  0  1  0  1  2  0  2  142  100  50  1  1  2  3  13  0  1 a Age at which survivors of the respective groups were killed.
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Research. Higher doses of BP significantly increased tumor incidence and shortened the time of their emergence in males given carcinogen at birth (p < 0.05). In the 15-day-old animals, the higher dose resulted in reduced longevity (Table 4) so that a significant difference in tumor incidence was observed between groups of mice treated at ! and 15 days of age, respectively (B6C3F~, 81% versus 58%, p < 0.01; C3AF~, 46% versus 23%, p < 0.05).
Of the 2 strains, the B6C3F~ hybrids developed hepatomas at a significantly higher incidence. Thus, all 4 experimental conditions, i.e., age, sex, dose, and strain, modulated hepatocarcinogenesis by BP.
Lung Tumors. Data on the incidence of multiplicity of lung tumors are presented in Table 4 . Of the 2 strains, the C3AF~ mice developed significantly more tumors than did the B6C3F~ hybrids (p < 0.001); multiplicity of lung tumors was also higher in the former hybrid strain.
The lower susceptibility of B6C3F1 enabled demonstration of variation in tumor incidence in relation to age and dose. Thus, both sexes developed lung tumors with higher incidence when treated with BP at birth than at 15 or 42 days of age (p < 0.05). Higher doses of BP, however, significantly enhanced lung carcinogenesis in newborn B6C3F1 female mice (p < 0.05).
Stomach Tumors. Table 5 lists data on the incidence of stomach tumors, equally represented by squamous cell papillomas and carcinomas. Regardless of age and sex, 97 of 583 (17%) mice exposed to the low dose of BP developed stomach tumors. With the high dose, this incidence was increased to 30%, mainly due to the consistently high response of animals treated at 15 or 42 days of age: Animals treated with the higher dose at birth were consistently less responsive (62 of 415; 15%) than were mice given the carcinogen in infancy (119 of 430; 28%) or in young adulthood (103 of 329; 31%). In contrast to tumor development in liver and lungs, no strain and sex differences were observed with regard to development of tumors in the gastric epithelium. Lymphoreticular Tumors. Both "dose" groups for each strain were combined because no statistically significant difference between the 2 dose levels was observed. Table 6 , therefore, presents the incidence of lymphoreticular tumors in relation to age, sex, and strain. Data show that the age at which mice received BP had a modifying effect upon tissue response. Thus, when the treatment was initiated within the 1st 24 hr after birth, 23% of males and 43% of females developed lymphoreticular tumors. When BP was given at 6 weeks of age, however, 45% of males and 61% of females developed tumors. This positive age-associated difference in the incidence of lymphoreticular tumors was statistically significant in both sexes (p < 0.001 for males; p < 0.05 for females).
The overall incidence of lymphoreticular tumors in the B6C3F1 hybrids was 32% (104 of 327) and 52% (148 of 283) for males and females, respectively (p < 0.001). This sex-associated difference was primarily due to development of reticulum cell sarcomas, as reported elsewhere (18) .
The C3AF1 strain was significantly less responsive to BP treatment than were B6C3F1 mice [76 of 564 (13%) versus 252 of 610 (41%); p < 0.001]. The increase in the incidence of lymphoreticular tumors with the age of the animals at exposure to BP was observed only in females, which were also more responsive than similarly treated males [50 of 274 (18%) versus 26 of 290 (9%); p < 0.001].
Miscellaneous Tumors. In addition to the above-mentioned tumors which were observed with sufficiently high frequencies to make possible the assessment of the role of various experimental conditions on their development, various tumors were observed at other sites at levels too low to permit any such evaluation. For this reason, percentages for all tumors that appeared in a particular tissue were combined for males and females of each of the strains, except for those tumors developing in sex organs, and results are presented in Table 7 . Corresponding values for the nontreated controls are also included. Statistical analyses of the data revealed a BP effect only in 3 tissues, namely, kidneys (p < 0.10 in B6C3F1;p < 0.01 in C3AF1), ovaries (p < 0.01 in both hybrid strains), and uteri (p < 0.05 in both strains). Kidney tumors encompassed papillary adenomas and adenocarcinomas. Ovarian tumors included tubular adenomas and granulosa cell tumors, while uterine tumors were mostly mesenchymal sarcomas. The latter type of tumor was also seen arising occasionally from the soft M  l  34  80  46  69  93  78  6  92  70  8  15  27  90  23  77  93  87  5  94  75  6  42  0  3  79  93  91  5  87  85  6   F  l  2  91  2  70  93  82  7  93  73  7  15  2  102  2  62  94  98  5  91  79  6  42  0  0  87  93  5  90  83  6 a Age at which animals received i.p. injections of BP, dissolved in trioctanoin, and delivered in the amounts specified.
Ratio of number of mice bearing liver or lung tumors to effective number expressed as a percentage. ~' Average age at which tumors were observed, a Average number of grossly visible lung tumors per whole lung. Table 5 Incidence Of stomach tumors a Age at which animals were given BP.
Sex
Ratio of number of mice hearing stomach tumors to effective number expressed as a percentage.
c Average age at which lHmors were observed. retroperitoneal tissues. In addition, between the 2 strains there were 5 cases of pancreatic ductal papillary adenomas and adenocarcinomas (Table 3) .
DISCUSSION
The main objective of this series of experiments was to assess the roles of age, sex, strain, and dose of BP on carcinogenesis in various tissues so that one could define the optimal biological conditions favoring carcinogenesis by polycyclic aromatic hydrocarbons and compare them with conditions favoring carcinogenesis by representatives of other classes of carcinogens in the same biological system. The summary of the results presented in Table 8 illustrates trends in factors influencing carcinogenesis similar to those recently reported for ENU (19) .
In both strains, the age of the animals at the time of exposure to BP has been the most effective modulator of carcinogenesis in liver, lung, stomach, and lymphoreticular system. Newborn and infant mice developed liver and lung carcinogenesis more readily than did young adults. In contrast, infant and young adult mice were more prone to stomach and lymphoreticular system tumorigenesis. This is consistent with the observed high incidence of pulmonary tumors in newborns (9, 12, 16, 17) and gastric tumors in adult mice (1, 3, 11, 13) and lymphoreticular tumors. Males were consistently more responsive to hepatocarcinogenesis (12) , while females developed malignant lymphomas with greater frequency. Of the 2 hybrids, the C3AF1 mice were more susceptible to lung and kidney carcinogenesis, whereas B6C3F1 mice developed hepatomas and lymphoreticular tumors more frequently. The higher dose of BP significantly enhanced development of hepatomas (newborn males), lung tumors (newborns), and stomach tumors (both sexes).
The data show that the spectrum of tumors induced by BP (Table 3) has been strikingly narrower than that reported for the ENU series (19) . In the latter case, 59 primary tumors were observed in 22 tissues; whereas in the current study, only 19 primary tumors developed in 9 organs. This difference may be attributed to physicochemical properties of the agents, mechanisms of their activation to ultimate carcinogenic moieties and catabolic removal, and the administered molar doses. Thus, while ENU is water soluble and spontaneously undergoes rapid heterolytic decomposition, BP has low solubility in aqueous media and requires, for its activation, specific aryl hydrocarbon hydroxylases, the levels of which may vary between tissues and strains (4, 7) . Comparison of tumor responses to approximately isomolar doses of these 2 agents (150 ug of BP per g versus 60 #g of ENU per g) showed lower carcinogenicity of BP to lungs, liver and kidneys. Thus, differences in the solubility and the activation of these 2 agents appear to be directly related to variations in their carcinogenicity.
Although the high susceptibility of the newborn animal to chemical carcinogens had been repeatedly demonstrated, few studies were designed to evaluate concurrently the age-associated differences in response to specific carcinogens (15, 20) . An overall view of the present data indicates that the preweaning animals are more sensitive to carcinogenic response than the adults are. The common features of tissues during the infant age period, namely, relative cell immaturity, high rate of macromolecular synthesis, and a consequently high rate of cell replication, as well as low immunological competence, are probably causally related to the high susceptibility of tissues to the inception of carcinogenesis and earlier expression of tumor development.
